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1. Introduction 
The “phosphorescence oxygen analyzer” and its use to monitor O2 consumption by cells and 
tissues are discussed in this chapter (Lo et al., 1996; Souid et al., 2003). This analytical tool 
assesses bioenergetics in cells undergoing apoptosis (e.g., the mitochondrial cell death 
pathway), in cells exposed to toxins (e.g., loss of viability) and in cells with a genetically 
altered energy metabolism (e.g., mitochondrial disorders) (Tacka et al., 2004a-b; Tao et al., 
2007; Tao et al., 2008a). This method is applicable to suspended (e.g., Jurkat and HL-60 cells) 
and adherent (TU183 human oral cancer cells) cells and to fresh tissues from humans (e.g., 
lymphocytes, spermatozoa and tumors) and animals (e.g., liver, spleen, heart, pancreas and 
kidney) (Badawy et al., 2009a-b; Whyte et al., 2010; Al Shamsi et al., 2010; Al-Salam et al., 
2011; Al Samri et al., 2011). The analyzer allows investigating anticancer compounds (single 
agents or combinations) for dosing, order of administration and exposure (Jones et al., 2009; 
Tao et al., 2008b; Souid et al., 2006; Goodisman et al., 2006; Tao et al., 2006a-b; Tack et al. 
2004b). It can also be used to monitor reactions consuming or producing O2 (Tao et al., 
2008b; Tao et al., 2009). 
2. Relevant biological processes 
The term “cellular bioenergetics” describes the biochemical processes involved in energy 
metabolism (energy conversion or transformation), while the term “cellular respiration” 
describes delivery of O2 to the mitochondria, the breakdown of reduced metabolic fuels with 
passage of electrons to O2, and the resulting synthesis of ATP. Impaired respiration thus 
implies any abnormality involving cellular bioenergetics, including glycolysis. The term 
“apoptosis” describes cellular mechanisms responsible for initiating and executing cell death. 
The initiation step requires a leakage of cytochrome c from the mitochondrial 
intermembrane to the cytosol. In the cytosol, cytochrome c binds to the apoptotic protease 
activating factor-1 (Apaf-1), triggering the caspase cascade (a series of cysteine, aspartate-
specific proteases). Caspase activation executes mitochondrial dysfunction (Nicholson et al., 
1997). This mitochondrial perturbation involves opening the permeability transition pores 
(accelerating oxidations in the mitochondrial respiratory chain) and collapsing the 
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electrochemical potential Δψ (Ricci et al., 2004). Thus, induction of apoptosis is directly 
linked to mitochondrial dysfunction (Green and Kroemer, 2004). 
3. Expressions of dissolved oxygen 
Dissolved O2 is expressed in mm Hg, mL O2 per L, mg O2 per L, or mol per L (M). For 
conversion, a partial pressure of O2 (PO2) of 1.0 mm Hg = 0.03 mL O2 per L; 1.0 mL O2 per L 
= 1.4276 mg O2 per L; and 1.0 mg O2 per L = 1000/32 M. In freshwater at 760 mm Hg and 
20°C, dissolved [O2] is 9.1 mg/L, or 284 M. Using a Clark electrode, PO2 of the reaction 
mixture phosphate-buffer saline (PBS), 10 mM glucose and 0.5% fat-free bovine serum 
albumin is 170.5 + 6.6 mm Hg (n = 4), or 228 + 9 M. The 56 mm Hg difference between [O2] 
in freshwater and the reaction solution reflects the effect of salinity on dissolved O2 (Weiss, 
1970). 
4. Principles and tools of the oxygen measurement 
O2 concentration is determined from the phosphorescence decay rate (1/) of the palladium 
(II) complex of meso-tetra-(4-sulfonatophenyl)-tetrabenzoporphyrin (Pd phosphor). This 
measurement is based on quenching the phosphorescence of Pd phosphor by O2 (Lo et al., 
1996). The probe has an absorption maximum at 625 nm and an emission maximum at 800 
nm. Samples are exposed to light flashes (10 per sec) from a pulsed light-emitting diode 
array with peak output at 625 nm (OTL630A-5-10-66-E, Opto Technology, Inc), Wheeling, 
IL. Emitted phosphorescent light is detected by a Hamamatsu photomultiplier tube (PMT 
#928) after first passing it through a wide-band interference filter centered at 800 nm. 
Amplified phosphorescence is digitized at 1-2 MHz using an analog/digital converter (PCI-
DAS 4020/12 I/O Board) with 1 to 20 MHz outputs (Computer Boards, Inc.). Pulses are 
captured using a developed software program at 0.1 to 4.0 MHz, depending on speed of the 
computer (Souid, 2003). 
The values of 1/ are linear with dissolved O2 concentration: 1kq[O2], where 1/ = 
the phosphorescence decay rate in the presence of O2, 1/o = the phosphorescence decay 
rate in the absence of O2, and kq = the second-order O2 quenching rate constant in sec-1 M-1 
(Lo et al., 1996). 
Cellular respiration is measured at 37oC in 1-mL sealed vials. Mixing is carried out with the 
aid of parylene-coated stirring bars. The respiratory substrates are the endogenous 
metabolic fuels supplemented with glucose. In cell suspensions sealed from air, [O2] 
decreased linearly with time, indicating the kinetics of cellular mitochondrial O2 
consumption is zero-order. The rate of respiration (k, in M O2 min-1) is thus the negative of 
the slope d [O2]/dt. Cyanide markedly inhibited respiration, confirming O2 is consumed 
mainly by the mitochondrial respiratory chain. 
5. Developed software program and instrument description 
The software program was developed using Microsoft Visual Basic 6 (VB6) programming 
language, Microsoft Access Database 2007 (Access) database management system, and 
Universal Library components developed by the electronic board company, Measurement 
Computing, for use with Microsoft Visual Basic 6 programming language 
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(http://www.mccdaq.com/daq-software/universal-library.aspx). It allows direct reading 
from the PCI-DAS 4020/12 I/O Board (http://www.mccdaq.com/pci-data-
acquisition/PCI-DAS4020-12.aspx). The software utilizes a relational database that stores 
experiments, pulses and pulse metadata, including slopes. Pulse identification is performed 
by detecting 10 phosphorescence intensities above 1.0 volt (by default). Peak identification is 
performed by the program which detects the highest 10% data points of a pulse and chooses 
the point in the group that is closest to the pulse’s decay curve. Depending on the sample 
rate, a minimum number of data points per pulse is set and used as a cutoff to remove 
invalid pulses with too few data points (Shaban, 2010). 
Main advantages of the developed program over commercially available packages (e.g., 
DASYLab™ or TracerDAQ™) are provision of full control and customization of the data 
acquisition, storage and analysis. The choices of VB6 and Access as programming and 
storage environments are due to their availability, simplicity, widespread use and VB6 
components that read directly from the PCI card made available by Measurement 
Computing. Table 1 displays identified tasks of the program. Fig. 1 shows a picture of the 
data acquisition system and the developed software program. Fig. 2 shows a reaction vial. 
 
Experiment identification (title, date, time and sample rate) 
Reading directly from the PCI card at the fastest possible rate 
Distinguishing pulse data from non-pulse data 
Allowing a fuzzy detection of the pulse peak 
Calculating the exponential decay rate (1/) and lifetime () of each pulse 
Storing each pulse data points, along with the peak, decay and lifetime values 
Viewing a representative pulse every 10 sec 
Viewing decay rates (1/) in a second graph 
Ability to pause and place a marker with a note 
Ability to remove erroneous (incomplete) pulses and adjust peak values if necessary 
Ability to copy pulse or slope data to clipboard for further analysis 
Ability to access a previous experiment, review a pulse with its metadata, markers and 
associated notes 
Table 1. Identified tasks of the customized software program for data acquisition, storage 
and analysis 
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The components (panel A, left to right) are circulating water bath, power supply for the mixer, sample 
chamber (panel B) attached to PMT, high voltage power supply for PMT, computer with PCI-DAS 
board, and monitor with developed software running. The PMT is connected to PCI-DAS board on the 
back of the computer. The developed software program interface is shown in panel C. 
Fig. 1. The data acquisition system and developed software program. 
 
 
Fig. 2. A sealed reaction vial containing Pd phosphor solution, stirring bar and a mouse liver 
specimen. 
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6. Instrument calibration 
The instrument was calibrated with -glucose and glucose oxidase system. 
-glucose + O2 glucono--lactone + H2O2 
The reaction contained PBS, 3 M Pd phosphor, 0.5% fat-free albumin, 50 g/mL glucose 
oxidase and various concentrations of -glucose. To achieve a high signal-to-nose ratio 
throughout the entire range of [O2], the photomultiplier tube was operated at 450 volts. 
Representative pulses (with exponential fits) for reactions containing PBS with 0, 125 or 500 
M -glucose, 50 g/mL glucose oxidase, 3 M Pd phosphor and 0.5% fat-free bovine 
serum albumin are shown in Fig. 3. 
 
 
Fig. 3. Representative phosphorescence pulses for reaction mixtures containing 0, 125 or 500 
M glucose. The lines are exponential fits (R2 >0.924, >0.985 and >0.992, respectively). 
The values of 1/ (mean + SD, n = 1200 over 2 min) as function of [-glucose] are shown in 
Fig. 4. The line is linear fit and the value of kq (101.1 sec-1 M-1) is the negatives of the slope. 
The value of 1/forair-saturated solution (without glucose) was 28,330 sec-1 (coefficient of 
variation, Cv = 12%), for [-glucose] = 125 M 5,650 sec-1, and for O2-depleted solution 
(with500 M glucose, 1/ 2,875 sec-1 (Cv = 1%). The high values of Cv for the air-
saturated solutions were due to the lower phosphorescence intensities with high [O2] (little 
light reaching the photomultiplier tube). The corresponding lifetimes () were 52 sec,  
177 sec and 352 sec, respectively. Oxygen concentration was calculated using,  
 kq[O2]. 
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The reaction mixtures contained PBS, 3 M Pd phosphor, 0.5% fat-free bovine serum albumin, 50 
g/mL glucose oxidase and shown concentrations of β-glucose. The values of 1/τ (mean ± SD, n = 1200 
flashes over 2 min) as a function of [β-glucose] are shown. The lines are linear fits. 
Fig. 4. Calibration with -glucose plus glucose oxidase 
7. Aflatoxin B1 impairs human lymphocyte respiration 
Aflatoxins (most notably, aflatoxin B1) are highly carcinogenic compounds, commonly 
found in food contaminated by aspergillus flavus, parasiticus and penicillium species 
(Williams, et al., 2004; Eaton & Gallagher, 1994). These potent mycotoxins create major 
health problems, especially where food storage is subjected to heat and humidity. A high 
rate of dietary exposure is reported in Sahara Africa, China and Taiwan. For example, in 
eastern China (where liver cancer exceeds 1 per 10,000 population per year), an average 
human exposure to aflatoxins is estimated to be 2.2g/kg/day. For comparison, the 
exposure in the United States is about 3 orders of magnitude less (Wang et al., 1996). 
Biotransformation of aflatoxin B1 is critical for its activation. The parent compound 
undergoes oxidation by monooxygenases, especially the hepatic cytochrome P450 3A4. The 
active metabolite, AFB exo-8,9-epoxide, undergoes base-catalyzed rearrangement to a 
dialdehyde, which rapidly reacts with guanyl N7 in DNA and lysine in proteins (Johnson et 
al., 1996). 
Exposure to aflatoxin B1 has been associated with hepatocellular carcinoma (Montesano et 
al., 1997), mutagenesis (e.g., in the tumor suppressor gene p53) and immune suppression 
(Corrier, 1991). Most of the information on immunotoxicity of aflatoxin B1 is derived from 
animal studies (Stec et al., 2009; Reddy et al., 1987; Reddy et al., 1989; Jiang et al., 2008; 
reviewed in Williams, et al., 2004]. In healthy humans, exposure to aflatoxin B1 is associated 
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with lower perforin (a cytolytic protein produced by natural killer lymphocytes) expression 
on CD8+ T-lymphocytes (Jiang et al., 2008). A dose-related decrease in DNA synthesis in 
lymphocyte cultures (with and without mitogens) is found in mice exposed in vivo to 
aflatoxin B1 (Reddy et al., 1987). A decrease in DNA synthesis is also observed in normal 
splenic mouse lymphocytes cultured in vitro with >10 M aflatoxin B1; a decrease in RNA 
synthesis is observed at dosing >25 M and a decrease in protein synthesis at dosing >100 
M (Reddy et al., 1989). 
The phosphorescence oxygen analyzer is used to monitor the effects of aflatoxin B1 on 
human lymphocyte mitochondrial oxygen consumption. These experiments investigate 
whether aflatoxin B1 impairs respiration of the lymphoid tissue, an organ that is typically 
targeted by this potent mycotoxin. Aflatoxin B1 (1.0 mg = 3.2 micromol) was freshly 
dissolved in 1.0 mL dry methanol and immediately added to cell suspensions with vigorous 
mixing. Alternatively, aflatoxin B1 powder was directly added to the cell suspension with 
vigorous mixing. The concentrations were determined by the absorbance at 350 nm (10 L 
aflatoxin B1 stock solution or cell-free supernatant in 1.0 mL dry methanol), using an 
extinction coefficient of 21,500 M-1 cm-1 (Nesheim et al., 1999); the aflatoxin B1 excitation 
wavelength is 366 nm and the emission wavelength 455 nm. The reactions were carried out 
in glass vials and protected from light. 
PBMC (0.6 x 107 cells/mL) were suspended in 6.0 mL PBS, 10 mM glucose, 3 M Pd 
phosphor and 0.5% fat-free bovine serum albumin. The mixture was divided into 2 equal 
aliquots. Methanol (25 L per mL, Fig. 5, left panel) or aflatoxin B1 (25 M, Fig. 5, right 
panel) was then added and the incubation continued at 37oC (open to air with gentle 
stirring). At t = 10 and 110 min, 1.0 mL of each mixture was simultaneously placed in the 
instruments for O2 measurement. The rate of respiration (k, in M O2 min-1) for t = 10 to 78 
min for the methanol-treated cells was 2.0 and for the aflatoxin B1-treated cells 2.1. The 
values of k for t = 110 to 174 were 2.2 and 1.2, respectively (corresponding to 45% inhibition 
of lymphocyte respiration). 
 
 
PBMC were incubated at 37oC with 25 μL per mL methanol (left panel) or 25 μM aflatoxin B1 (right 
panel). Minute zero corresponds to the addition of aflatoxin B1. At t = 10 and t = 110 min, 1.0 mL of each 
mixture was simultaneously placed in the instruments for O2 measurement. Rates of respiration (k) 
were calculated from the best-fit linear curves. Additions of 5.0 mM NaCN and 50 g/mL glucose 
oxidase are shown. 
Fig. 5. Effect of aflatoxin B1 on human PBMC respiration. 
www.intechopen.com
 
Bioenergetics 
 
244 
The time-course for aflatoxin B1-induced inhibition of lymphocyte respiration was 
investigated (Fig. 6). PBMC (1.3 x 107 cells/mL) were suspended in 3.0 mL PBS, 10 mM 
glucose and divided into 2 equal aliquots. Aflatoxin B1 powder was directly added to one 
aliquot with vigorous mixing (final concentration, ~75 M). The 2 aliquots were then 
incubated at 37oC for 60 min (open to air with continuous stirring). At t = 60 min, 5 mg 
albumin and 2.0 M Pd phosphor were added to each suspension. The samples were then 
simultaneously placed in the chambers for O2 measurement. For the untreated cells, O2 
consumption was linear with time (k = 2.4 M O2/min, R2 > 0.916). For the treated cells, O2 
consumption was exponential with time, R2 > 0.934. Changes at 5-min intervals for the 
treated cells showed a sharp decline in the values of k for t = 60 to 90 min, followed by a 
steady low rate for t = 95 to 175 min. In contrast, the values of k remained relatively stable 
for t = 60 to 140 min. The mean + SD (coefficient of variation) for the values of k for the 
untreated cells was 2.43 + 0.55 (Cv = 23%) and for the treated cells 1.56 + 1.80 (Cv = 87%); p-
value < 0.02 (Fig. 6, insert). 
 
 
The lines are linear fit for the untreated cells (R2 > 0.916) and exponential fit for the treated cells (R2 > 
0.936). Insert, changes in the values of k at 5-min intervals. 
Fig. 6. Time-course of the effect of aflatoxin B1 on human lymphocyte respiration. 
The exponential profile of O2 consumption in the presence of aflatoxin B1 is similar to 
dactinomycin (Tao et al., 2006b; Tao et al., 2008a). This pattern of bioenergetic derangements 
could stem from progressive mitochondrial and metabolic disturbances, ranging from 
uncoupling oxidative phosphorylation (which accelerates O2 consumption and rapidly 
depletes the metabolic fuels) to mitochondrial respiratory chain function collapse. 
Experimentally, these two phases are clearly distinguishable in our system (Fig. 6, insert). 
Caspase activation in lymphocytes treated with aflatoxin B1 was then examined. Many of 
the caspases (e.g., caspase-3, -2 and -7) target the asp-glu-Val-asp (DEVD) motif and cleave 
at sites next to the last aspartate residue (Nicholson et al., 1997).  Synthetic cell-permeable 
substrates, such as N-acetyl-DEVD-7-amino-4-trifluoromethyl coumarin (Ac-DEVD-AFC) 
and N-acetyl-DEVD-7-amino-4-methyl coumarin (Ac-DEVD-AMC) have been used to 
investigate caspase activities. For example, cleavage of Ac-DEVD-AFC by specific caspases 
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releases the fluorogenic AFC; the latter can be separated on HPLC and detected by 
fluorescence with a great sensitivity (Tao et al., 2007). 
Caspase-3 activity in lymphocytes exposed to aflatoxin B1 is shown in Fig. 7. The purpose of 
these experiments is to confirm caspases are activated within the time period required for 
inhibition of respiration. The mixtures (final volume, 0.5 mL) contained 1.5 x 106 cells in PBS, 
10 mM glucose and 68 M Ac-DEVD-AMC (N-acetyl-asp-glu-val-asp-7-amino-4-methyl 
coumarin, a caspase-3 substrate) with and without 20 M zVAD-fmk (benzyloxycarbonyl-
val-ala-DL-asp-fluoromethylketone, a pan-caspase inhibitor) (Slee et al., 1996). The 
suspensions were incubated at 37oC for 2 hr without other additions (Fig. 7, left panel) or 
with the addition of ~100 M aflatoxin B1 (Fig. 7, right panel). At the end of the incubation 
period, the cells were disrupted and their supernatants were separated on HPLC and 
monitored by fluorescence. The results show AMC moieties (the cleavage product of Ac-
DEVD-AMC) appear in the cells about 2 hr after the addition of aflatoxin B1. This 2-hr 
period is the same as that observed for aflatoxin B1-induced inhibition of respiration (see 
Fig. 5). Thus, the results suggest aflatoxin B1 impairs human lymphocyte mitochondrial 
function by activating caspases. 
The above findings also demonstrate the lymphocyte preparation contain monooxygenases 
that activate aflatoxin B1. These results are consistent with previous reports (Stec et al., 2009; 
Rossano et al., 1999; Savel et al., 1970; Wang et al., 1999). In one study, the addition of 
aflatoxins B1 at concentrations up to 32 M had a minimum effect on phytohemagglutinin-
p-stimulated human lymphocyte proliferation (Meky et al., 2001). However, an earlier study 
on human lymphocytes by Savel et al. (1970) showed a reduced phytohemagglutinin-p-
stimulated lymphocyte proliferation with 16 M aflatoxin B1. More recently, aflatoxin B1 
was shown to inhibit in vitro concanavalin A-induced proliferation of pig blood 
lymphocytes; in 72-hr cultures, the concentration of aflatoxin B1 producing 50% inhibition 
(IC50) was 60 nM (Stec et al., 2009). In other studies, aflatoxin G1 induced in vitro apoptosis 
in human lymphocytes (Wang et al., 1999; Sun et al., 2002). In summary, the data presented 
show human lymphocytes exposed in vitro to aflatoxin B1 exhibit impairments of cellular 
respiration, which could result from caspase activation. The results substantiate the potent 
immunosuppressive activity of aflatoxins in human. 
8. Measurement of O2 consumption in murine tissues 
A novel in vitro system is developed to measure O2 consumption by various murine tissues 
over several hours (Al-Salam et al., 2011; Al Samri et al., 2011; Al Shamsi et al., 2010). Small 
tissue specimens excised from male Balb/c mice were immediately immersed in ice-cold 
Krebs-Henseleit buffer (115 mM NaCL, 25 mM NaHCO3, 1.23 mM NaH2PO4, 1.2 mM 
Na2SO4, 5.9 mM KCL, 1.25 mM CaCl2, 1.18 mM MgCl2 and 6 mM glucose, pH ~7.4), 
saturated with 95% O2:5% CO2. The samples were incubated at 37oC in the same buffer and 
continuously gassed with O2:CO2 (95:5). Normal tissue histology at hr 5 was confirmed by 
light and electron microscopy. NaCN inhibited O2 consumption, confirming the oxidation 
occurred in the mitochondrial respiratory chain. A representative experiment of 
pneumatocyte respiration is shown in Fig. 8. The rate of lung tissue respiration incubated in 
vitro for 3.9 < t <12.4 hr was 0.24 ± 0.03 M O2 min-1 mg-1 (mean ± SD, n = 28). The 
corresponding rate for the liver was 0.27 ± 0.13 (n = 11, t <4.7 hr), spleen 0.28 ± 0.07 (t <5 hr, 
n = 10), kidney 0.34 ± 0.12 (t <5 hr, n = 7) and pancreas 0.35 ± 0.09 (t <4 hr, n = 10), Table 2. 
This approach provided accurate assessment of tissue bioenergetics in vitro over several 
hours. 
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The reactions contained 1.5 x 106 cells in PBS plus 10 mM glucose and 68 M Ac-DEVD-AMC with and 
without 20 μM zVAD-fmk. The suspensions were incubated at 37oC for 2 hr without other additions 
(left panel) or with the addition of ~100 M aflatoxin (right panel). At the end of the incubation period, 
the cells were disrupted and their supernatants were separated on HPLC and monitored by 
fluorescence. The retention time for Ac-DEVD-AMC was ~2.4 min and for the released AMC ~8.7 min. 
Fig. 7. Caspase activation by aflatoxin B1 in human peripheral blood mononuclear cells 
parenthesis for PBMC:PBMC 
 
 
Specimens were excised from the lung of an anesthetized mouse and immediately immersed in ice-cold 
Krebs-Henseleit buffer saturated with 95% O2:5% CO2. The samples were incubated at 37oC in the same 
buffer with continuous gassing with O2:5%CO2. At indicated time periods, specimens were removed 
from the incubation mixture, weighed and placed in Krebs-Henseleit buffer containing 0.5% albumin 
and 3 μM Pd phosphor for O2 measurement. The rate of respiration was set as the negative of the slope 
of [O2] vs. time. The weight is shown at the top and the respiration rate (in μM O2 min-1 mg-1) at the 
bottom of each run (Al Samri et al., 2011). 
Fig. 8. Representative experiment of O2 consumption by lung tissue. 
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Tissues 
Respiration 
(M O2 min-1 mg-1) 
Lung 0.24 ± 0.03 
Liver 0.27 ± 0.13 
Spleen 0.28 ± 0.07 
Kidney 0.34 ± 0.12 
Pancreas 0.35 ± 0.09 
Values are mean ± SD. For unit conversion, 1.0 mL O2 = 1.4276 mg or 0.0446125 mmol. 
Table 2. O2 consumption by murine tissues. 
9. Biocompatibility of calcined mesoporous silica particles with murine 
tissue bioenergetics 
The in vitro system discussed in Section 8 is used to investigate the effects of two forms of 
calcined mesoporous silica particles (MCM41-cal and SBA15-cal) on cellular respiration of 
mouse tissues (Al Shamsi et al., 2010; Al-Salam et al., 2011; Tao et al., 2008c). O2 
consumption by lung, liver, kidney, spleen and pancreatic tissues was unaffected by 
exposure to 200 g/mL MCM41-cal or SBA15-cal for several hours. A representative 
experiment of pneumatocyte respiration is shown in Fig. 9. 
 
 
The rate of respiration (k) was set as negative of the slope of [O2] vs. time; the values of k  
(in M O2 min-1 mg-1) are shown at the bottom of the runs. Zero minute corresponds to the addition of 
the particles. U, untreated; and T, treated. 
Fig. 9. Pneumatocyte respiration with and without 200 g/mL MCM41-cal. 
Normal tissue architecture and histology were confirmed by light microscopy. Intracellular 
accumulation of the particles in the studied tissues was evident by electron microscopy. The 
results show reasonable in vitro biocompatibility of the mesoporous silicas with murine 
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tissue bioenergetics. Therefore, the measurements of respiration can be used to explore 
biocompatibility and viability of tissues and cells as a result of various treatments. 
10. Liver tissue bioenergetics in concanavalin A hepatitis in mice 
Concanavalin A (Con A) is a plant lectin from the seeds of Canavalia ensiformis (jack bean). 
This toxin serves as a polyclonal T-cell mitogen. It produces fulminant hepatitis in mice, a 
disease that mimics human infection with hepatitis B virus (Tiegs et al., 1992 & 1997). The 
hepatic injury is typically noted within 3 hr of intravenous injection of > 1.5 mg/kg of Con 
A and progresses with time (Tiegs et al., 1992). Activation and recruitment of Natural Killer 
(NK) T-cells and other cells of the innate immune system are early events, which lead to 
increased secretion of various inflammatory cytokines (e.g., TNF-, IL-2, IL-10, IL-12 and 
IFN-) (Takeda et al., 2000; Margalit et al., 2005; Chen et al., 2010; Sass et al., 2002). This 
immune response targets multiple organs including the liver. Its outcome is irreversible 
hepatotoxicity, which includes inflammatory infiltrates and necrosis (Leist et al., 1996). 
The above described in vitro system is employed to assess liver tissue respiration in Con A 
treated C57BL/6 mice. The purpose of the work was to estimate hepatocyte bioenergetics in 
this well-studied hepatitis model. The mice were injected intravenously with 12 mg/kg Con 
A or PBS. Specimens (20 to 30 mg each) were cut from the liver of anesthetized (urethane, 
100 L per 10 g body weight, using 25% solution, w/v, in 0.9% NaCl) mice using a sharp 
scissor (Moria Vannas Wolg Spring, cat. # ST15024-10) (Al Samri et al., 2011). The specimens 
were immediately immersed in ice-cold Krebs-Henseleit buffer (115 mM NaCl, 25 mM 
NaHCO3, 1.23 mM NaH2PO4, 1.2 mM Na2SO4, 5.9 mM KCl, 1.25 mM CaCl2, 1.18 mM MgCl2 
and 6 mM glucose, pH ~7.2), gassed with 95% O2:5% CO2. Pieces were then weighed and 
placed in 1-ml Pd phosphor solution (Krebes-Henseleit buffer containing 0.5% albumin and 
3 M Pd phosphor) for O2 measurement. The results are summarized in Table 3. 
 
Strain Treatment 
kc
(M O2 min-1 mg-1) 
mean + SD (n) range 
C57Bl/6 
PBS 0.26 + 0.04 (5) 0.22 – 0.32 
12 mg/kg Con A 0.18 + 0.03 (5)* 0.13 – 0.20 
  
 
* P-value = 0.005 
 
Table 3. Liver tissue respiration in Con A treated C57BL/6 mice. Mice were injected with 
Con A or PBS. Liver specimens were collected 12 hr post injection. 
A representative experiment following 3-hr treatment is shown in Fig. 10. Liver tissue 
respiration was measured 3 hr post injection of PBS (Fig. 10, left panel) or 12 mg/kg Con A 
(Fig. 10, right panel). In untreated mouse, the rates of respiration at t = 0 min and t = 80 min 
(post tissue collection) were similar. In Con A-treated mouse, the rate of respiration at t = 0 
min was high and at t = 40 min it was low. Thus, at 3-hr, Con A treatment doubled the rate 
of liver tissue O2 consumption. However, respiration deteriorated in vitro in 40 min. 
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Minutes zero correspond to collecting the liver tissue specimens at 3 hr post injections. Two runs were 
done for each condition. Rates of respiration (kc, in μM O2 min-1 mg-1) are shown at the bottom of the 
runs. 
Fig. 10. Representative experiment for liver tissue respiration in C57BL/6 mice 3 hr post 
injection of PBS (left panel) or 12 mg/kg Con A (right panel) 
Thus, Con A treatment produced a concurrent impairment of hepatocyte respiration. The 
lower rate of respiration at 12 hr post treatment (Table 3) concurred with large areas of 
necrosis and the enhanced rate of respiration at ~3 hr post treatment (Fig. 10) concurred 
with inflammatory infiltrates limited to the perivascular space without any notable necrosis. 
The latter finding suggests a role for inflammatory mediators, such as TNF- and IL-2 (both 
known to peak 3 hr post Con A treatment) in modulating hepatocyte energy metabolism 
(Louis et al., 1997; Gottlieb et al., 2000).  The mechanism for the presumed inflammation-
induced increase in hepatocyte oxygen consumption could be uncoupling oxidative 
phosphorylation vs. up-regulating the energy metabolism. Nevertheless, for both 
assumptions, there is a large demand for energy supply to prevent fulminant liver necrosis. 
In an in vitro experiment, liver tissue respiration was measured with and without IL-2 
(added directly to the O2 measuring vial). The rate of respiration without IL-2 was 0.21 M 
O2 min-1 mg-1 and with IL-2 0.087 M O2 min-1 mg-1 (~60% inhibition). Thus, similar to TNF-
, IL-2 also inhibits cellular respiration in vitro (Gottlieb et al., 2000). 
11. Spermatozoa respiration 
The above in vitro system was also used to measure human spermatozoa respiration. O2 
concentrations in solutions containing glucose and human spermatozoa declined linearly 
with time. Sodium cyanide also inhibited sperm oxygen consumption, confirming the 
oxidations occurred in the respiratory chain. The rate of respiration (mean + SD, n = 10) was 
1.0 + 0.3 M O2 min-1 per 108 sperm. Immediate decline in the rate of sperm respiration was 
noted when toxic agents [e.g., 4-hydroperoxycyclophosphamide (4OOH-CP), 9-
tetrahydrocannabinol (9-THC) or 8-tetrahydrocannabinol (8-THC)] were added to 
washed sperm or neat semen. The inhibition was concentration-dependent and irreversible 
(Badawy et al., 2009a-b). 
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The toxic effect of the cannabinoids was confirmed on isolated mitochondria from beef 
heart. The effect of 8-THC on respiration of beef heart mitochondria is shown in Fig. 11. 
The value of k (in M O2 min-1) decreased by 64% in the presence of 240 M 8-THC. 
 
 
Fig. 11. 8-THC added to isolated mitochondria from beef heart. 
12. Phosphorescence O2 analyzer as a screening tool for disorders of 
impaired cellular bioenergetics 
Disorders of cellular bioenergetics are challenging clinically and biochemically (Chretien 
and Rustin, 2003; Chretien et al., 1994; Rotig et al., 1990; Rustin et al., 1994). Their 
manifestations frequently overlap with numerous clinical entities. Furthermore, mutations 
that limit these processes in humans are incompletely identified 
(http://www.gen.emory.edu/mitomap.html) (Kogelnik et al., 1997). Therefore, clinicians 
usually rely on a laborious analysis of skin and muscle biopsies for diagnosis (Chretien and 
Rustin, 2003; Chretien et al., 1994; Rustin et al., 1994). As suggested by Rustin et al., 
laboratory evaluation of mitochondrial disorders require testing samples from multiple 
tissues. The authors also recommended the use of circulating lymphocytes in the initial 
screening (Rustin et al., 1994). These interrelations justify developing non-invasive simple 
screening methods that are applicable to various types of samples. Recently, Marriage et al. 
showed ATP synthesis in permeabilized lymphocytes is an effective screening tool for 
impaired oxidative phosphorylation (Marriage et al., 2003; Marriage et al., 2004). Decreased 
ATP synthesis in the lymphocytes was present in the 5 studied mitochondrial disorders 
(Marriage et al., 2003). 
Described herein is the use of the phosphorescence O2 analyzer to measure lymphocyte 
respiration in volunteers and a patient. The measurement primarily aimed to show 
feasibility of using the phosphorescence O2 analyzer to screen for clinical disorders with 
impaired cellular bioenergetics. Peripheral blood mononuclear cells (PBMC) were collected 
from healthy volunteers and patient. The rate of respiration (mean ± SD, in M O2 per min 
per 107 cells) for adult volunteers is 2.1 ± 0.8 (n = 18), for children 2.0 ± 0.9 (n = 20), and for 
newborns (umbilical cord samples) 0.8 ± 0.4 (n = 18, p <0.0001). Representative experiments 
of the volunteers are shown in Fig. 12. 
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Fig. 12. Left panel: Lymphocytes (1.0 x 107 cells/mL) were collected from a 9-year-old girl; 
the rate of respiration was 2.8 M O2 per min per 107 cells (R2 >0.942). Right panel: 
Lymphocytes (15 x 107 cells/mL) were collected from umbilical cord; the rate of respiration 
was 8.0 M O2 per min (R2 >0.934), or 0.5 M O2 per min per 107 cells. The additions of 5.0 
mM NaCN and 50 g/mL glucose oxidase are shown. 
For an 8-year-old patient with reduced muscle NADH dehydrogenase and pyruvate 
dehydrogenase activities, the rate was 0.7 ± 0.2 (n = 3) M O2 per min per 107 cells. 
As previously noted in muscle specimens, the rate of lymphocyte mitochondrial oxygen 
consumption is very similar in adults and children (p =0.801) (Chretien et al., 1994). 
However, cord blood cells have lower rates of respiration (p <0.001). This finding could be 
attributed to the high number of nucleated red blood cells in the umbilical cord blood. 
Fresh lymphocytes were previously used as a source of tissue for measuring respiratory 
chain enzymes by polarography (Clark-type O2 electrode) and spectroscopy (Chretien and 
Rustin, 2003; Chretien et al., 1994; Rustin et al., 1994). Rotig et al. reported a rate (mean + SD, 
n=15) of 3.5 + 0.5 nmol O2 per min per 107 cells (Rotig et al., 1990). Hedeskov and Esmann 
reported a rate of 2.0 + 0.07 nmol O2 per min per 107 for cell concentrations >4 x 107 per mL 
and higher rates for less concentrated cells (Hedeskov and Esmann, 1966). Pachman 
reported rate of 1.0 + 0.2 nmol O2 per min per 107 equine lymphocytes (Pachman, 1967). 
Clinical presentations of entities with impaired cellular bioenergetics vary markedly. Their 
manifestations may include progressive neuromuscular defects (e.g., psychomotor 
retardation and hypotonia), heart muscle involvement and encephalopathy. One typical 
example is Leigh syndrome, which results from an isolated mitochondrial complex I 
deficiency (Benit et al., 2004). This clinical heterogeneity stems from various mechanisms, 
including tissue-specific of nuclear-encoded isoforms of the respiratory chain and existence 
of normal and mutated mtDNA in the same organ (mtDNA heteroplasmy) (Rustin et al., 
1994). Therefore, as suggested by Rustin et al., the biochemical analysis should not be 
limited to skeletal muscle and skin tissues (Rustin et al., 1994). In one study, 42 patients with 
respiratory chain defects were investigated. The results showed that 50% of the patients had 
deficiencies in skeletal muscles and lymphocytes, 45% in skeletal muscles only, and 5% in 
lymphocytes only (Chretien et al., 1994). Patients with Pearson’s syndrome on the other 
hand consistently express defects in the lymphocyte (Rotig et al., 1990). 
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13. Conclusions 
A novel in vitro system that allows monitoring of cellular respiration over several hours is 
described. The method has numerous biological applications, including studying 
mitochondrial dysfunction during apoptosis or toxic exposure. It also allows screening for 
metabolic disorders in patients.  The procedure is sensitive and reproducible. It is applicable 
to cells in suspension, adherent cells and various organs, including the heart muscle, liver, 
spleen, pancreas and kidney. 
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